Intrust Bank Na Ani Pharmaceuticals Inc Transaction History

Intrust Bank Na

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$30.35 - $67.14 $108,379 - $239,756	-3,571 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$55.65 - $79.83 $4,396 - $6,306	-79 Reduced 2.16%	3,571 $221,000
Q3 2019 Nov 12, 2019	SELL	$64.7 - $85.39 $9,834 - $12,979	-152 Reduced 4.0%	3,650 $266,000
Q2 2019 Aug 12, 2019	SELL	$67.77 - $82.2 $4,337 - $5,260	-64 Reduced 1.66%	3,802 $313,000
Q1 2019 May 10, 2019	BUY	$45.83 - $70.54 $177,178 - $272,707	3,866 New	3,866 $273,000
Q4 2018 Feb 06, 2019	SELL	$41.17 - $56.44 $149,158 - $204,482	-3,623 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$52.95 - $71.34 $202,163 - $272,376	-3,818 Reduced 51.31%	3,623 $205,000
Q2 2018 Aug 08, 2018	BUY	$56.38 - $68.08 $30,727 - $37,103	545 Added 7.9%	7,441 $497,000
Q1 2018 May 03, 2018	BUY	$56.98 - $72.41 $15,270 - $19,405	268 Added 4.04%	6,896 $402,000
Q4 2017 Feb 08, 2018	BUY	$53.3 - $74.56 $54,259 - $75,902	1,018 Added 18.15%	6,628 $427,000
Q3 2017 Nov 06, 2017	BUY	$43.46 - $52.49 $243,810 - $294,468	5,610	5,610 $295,000

211

18.5M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

Stay updated on Intrust Bank Na with notifications on news.